ABL Bio Inc. (KOSDAQ: 298380)

ABL Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-40,003	-2,647	3,209	-43,558
Depreciation & Amortization	2,522	2,590	2,325	2,158
Loss (Gain) From Sale of Assets	0.52	2.64	-48	5.83
Loss (Gain) From Sale of Investments	-904.99	-1,132	592.13	-6,666
Stock-Based Compensation	4,049	6,001	4,382	7,521
Provision & Write-off of Bad Debts	-	-	-	-682.58
Other Operating Activities	3,012	-203.88	1,352	-15.18
Change in Unearned Revenue	-31,859	-31,859	63,562	-3,160
Change in Other Net Operating Assets	-1,711	-1,113	-3,242	3,792
Operating Cash Flow	-64,894	-28,362	72,132	-40,605
Capital Expenditures	-8,592	-5,740	-2,055	-1,244
Sale of Property, Plant & Equipment	2.91	7.46	74.51	12
Cash Acquisitions	-	-	-21,256	-
Sale (Purchase) of Intangibles	-54.91	-104.41	-330.07	-21.4
Investment in Securities	59,185	35,941	-46,234	21,458
Other Investing Activities	33.6	-20.49	-196.46	17.62
Investing Cash Flow	50,374	29,884	-71,250	20,221
Long-Term Debt Issued	-	44,831	-	-
Long-Term Debt Repaid	-	-43,130	-1,091	-959.45
Net Debt Issued (Repaid)	1,698	1,701	-1,091	-959.45
Issuance of Common Stock	1,738	1,717	5,753	1,256
Other Financing Activities	-1,981	-1,981	-11.67	-12.36
Financing Cash Flow	1,455	1,437	4,649	284.13
Foreign Exchange Rate Adjustments	-1,874	-29.86	-1,984	1,030
Net Cash Flow	-14,938	2,929	3,547	-19,070
Free Cash Flow	-73,486	-34,102	70,076	-41,850
Free Cash Flow Margin	-222.99%	-52.03%	104.12%	-784.87%
Free Cash Flow Per Share	-1534.13	-712.77	1473.24	-890.99
Cash Interest Paid	2,214	2,521	1,205	-
Cash Income Tax Paid	-	1,621	-2.6	-75.7
Levered Free Cash Flow	-65,816	-37,710	63,171	-
Unlevered Free Cash Flow	-65,284	-36,365	64,000	-
Change in Net Working Capital	34,020	32,186	-62,291	-

Source: S&P Capital IQ. Standard template. Financial Sources.